Independent valuations for management buyouts that must survive ATO, financier and shareholder scrutiny.

A management buyout valuation establishes the market value of the business or equity interest management is acquiring from the existing owner. Because an MBO is a related-party sale, the ATO, financiers and any non-participating shareholders each expect independent evidence of market value. Prismi prepares evidence-led MBO valuation reports across Australia — independent, senior-reviewed and documented so the price is defensible if reviewed.

When an MBO valuation is required

An MBO valuation is required whenever a business is sold to its own management team, because the ATO, the funder and any non-participating shareholders all need independent evidence that the price reflects market value rather than convenience. A management buyout is a related-party sale by nature — the buyers already run the business and neither side is a stranger negotiating at arm's length. That means the agreed price must satisfy three audiences who were not at the table: the ATO, which can apply the market value substitution rule (s 116-30 ITAA 1997) where parties are not dealing at arm's length and which reviews any small business CGT concession claim the vendor makes on exit; the financier funding the buyout, which needs an independent value to support security, serviceability and covenant settings; and any non-participating shareholders, who are entitled to evidence that the price is fair rather than convenient. Common triggers include founder retirement sales to a management team, staged succession buy-ins, partner exits funded by the remaining principals, and externally financed MBOs of a founder's controlling stake.

Related-party pricing and ATO market value expectations

The ATO's 'Market valuation for tax purposes' guidance expects market value in the Spencer v Commonwealth (1907) sense — the price a willing but not anxious buyer would pay a willing but not anxious seller, both fully informed. An MBO strains that test: management typically knows more about the business than any outside buyer would, and both sides have an incentive to land on a number that suits the funding or the tax outcome rather than the market. The defence is evidence neither side controls — normalised earnings with a documented add-back schedule (including management remuneration reset to market rates, which is frequently the largest normalisation in an MBO), methodology selection reasoned against alternatives, and a concluded position inside a supportable range. Reports are prepared under IVS 104 and APES 225 with ATO market valuation expectations in mind. No valuation is 'ATO-approved' — the value of the report is that the methodology, evidence and reasoning are documented so the position is defensible if reviewed.

Control value versus minority tranche pricing

Many MBOs are staged: management acquires an initial 20–40% with a pathway to control. A minority tranche is not simply a pro-rata slice of the 100% control value. Discounts for lack of control (DLOC) and lack of marketability (DLOM) must be considered, and their magnitude depends on the rights attaching to the tranche — pre-emptive rights, drag-along and tag-along provisions, put and call options over the balance, and any agreed pricing formula for future tranches in the shareholders' agreement. A call option that gives management a contractual path to control, for example, can materially reduce the discount appropriate to later tranches. Our reports document the discount reasoning for each tranche within a consistent framework, so that successive stage valuations reconcile with one another rather than producing unexplained jumps the ATO or a financier will query.

Vendor finance, earn-outs and the effective price

MBOs are rarely clean cash deals. Vendor loans at below-market interest rates, deferred consideration and earn-outs contingent on post-completion performance all mean the headline price and the effective price can differ substantially. Our reports distinguish the market value of the equity at the valuation date from the structure of the consideration, and quantify the value effect of deferred or contingent terms — deferred amounts assessed at present value, contingent amounts assessed against the assumptions that drive them. That separation gives the tax and legal advisers a clean base to work from. The tax treatment of the structure itself — including the look-through earn-out right rules and any Division 7A ITAA 1936 consequences where the company's own funds are used to finance the buyout — is a matter for the tax adviser. Prismi prepares independent valuations only and does not provide tax, legal or financial advice.

Independence: why one valuer cannot act for both sides

One valuer cannot act for both sides of an MBO because the vendor wants the highest supportable price and management wants the lowest, and an adviser retained to negotiate for one side cannot also give the other side independent assurance. A valuation shaped to get a deal done protects nobody when the ATO or a financier tests it later. Prismi acts as an independent valuer, not a negotiator for either party. Fees are fixed at engagement and never contingent on the outcome or on completion. The conclusion is determined by methodology and evidence; where either side demands a target value, we will say so and decline the engagement on those terms. Every report carries an independence statement and senior-reviewer sign-off, and the working file is retained for 10 years. Where the non-instructing side wants its own comfort, a second-opinion review of the report by another valuer is a cleaner path than a jointly negotiated number.

Documents we need

• ·Last 3–5 years of financial statements and current year-to-date management accounts
• ·Draft term sheet or heads of agreement, including vendor finance and earn-out terms
• ·Shareholders' agreement, option deeds and any agreed tranche pricing formula
• ·Share or unit register and the proposed staged ownership structure
• ·Financier term sheet or lending requirements, where the buyout is bank-funded
• ·Management remuneration schedule and related-party transactions for normalisation
• ·Forecasts or budgets underpinning any earn-out mechanics
• ·Details of any non-participating shareholders and their rights

Tier recommendation

Most MBO valuations sit at the Comprehensive tier (from $3,995 + GST, 15–25 business days), which suits a single-tranche buyout with conventional funding. Where the buyout is staged, includes vendor finance or earn-out terms, supports a small business CGT concession claim, or is likely to face ATO or financier scrutiny, the Defensible Valuation File (from $8,995 + GST, 25–35 business days) is the appropriate level. Complex adviser-led matters — multiple tranches over time, contested pricing between the parties, or scenario analysis across funding structures — warrant the Valuation Range & Scenario Review (from $12,995 + GST, 30–45 business days). The Essential tier (from $1,495 + GST) is generally not suited to MBO work given the related-party review risk. Additional entities are $750 each, historical valuation dates add $495 per date, and rush turnaround is available at +30%.